Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-03-2010 | Original Paper

Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008

Auteurs: Rebecca E. Rosenberg, David S. Mandell, Janet E. Farmer, J. Kiely Law, Alison R. Marvin, Paul A. Law

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2010

Abstract

Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD.

vorige artikel Further Empirical Data on the Psychoeducational Profile-Revised (PEP-R): Reliability and Validation with the Vineland Adaptive Behavior Scales

volgende artikel Mortality in Autism: A Prospective Longitudinal Community-Based Study

Alleen toegankelijk voor geautoriseerde gebruikers

Aman, M. G., Lam, K. S., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15(1), 116–126.CrossRefPubMed

Aman, M. G., & Langworthy, K. S. (2000). Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30(5), 451–459.CrossRefPubMed

American Society of Health System Pharmacists. (2006). AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists.

American Psychiatric Association. (2000). Disorders usually first diagnosed in infancy, childhood, or Adolescence. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (Fourth, Text Revision ed.). Arlington, VA: American Psychiatric Association. doi:10.1176/appi.books.9780890423349.

Bebbington, A., Anderson, A., Ravine, D., Fyfe, S., Pineda, M., de Klerk, N., et al. (2008). Investigating genotype–phenotype relationships in rett syndrome using an international data set. Neurology, 70(11), 868–875.CrossRefPubMed

Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999). Autism screening questionnaire: Diagnostic validity. The British Journal of Psychiatry: The Journal of Mental Science, 175, 444–451.CrossRef

Best, S. J., & Krueger, B. S. (2004). Internet data collection. Thousand Oaks, CA: Sage.

Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry (Revue Canadienne De Psychiatrie), 48(8), 506–516.

Chen, A. Y., & Chang, R. K. (2002). Factors associated with prescription drug expenditures among children: An analysis of the medical expenditure panel survey. Pediatrics, 109(5), 728–732.CrossRefPubMed

de Bildt, A., Mulder, E. J., Scheers, T., Minderaa, R. B., & Tobi, H. (2006). Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation. Pediatrics, 118(6), e1860–e1866.CrossRefPubMed

Farmer, J. E., Marvine, A., Law, K., & Anderson, C. (2009). The impact of urbanicity on diagnosis and treatment of ASD. Presented at IMFAR, Chicago, IL.

Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Jr, Dawson, G., et al. (2000). Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology, 55(4), 468–479.PubMed

Findling, R. L. (2005). Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. The Journal of Clinical Psychiatry, 66(Suppl 10), 26–31.PubMed

Gosling, S. D., Vazire, S., Srivastava, S., & John, O. P. (2004). Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. American Psychologist, 59(2), 93–104.CrossRefPubMed

Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84.CrossRefPubMed

Hewson, C., Yule, P., Laurent, D., & Vogel, C. (2003). Internet research methods: A practical guide for the social and behavioral sciences. London: Sage.

Hoagwood, K., Jensen, P. S., Feil, M., Vitiello, B., & Bhatara, V. S. (2000). Medication management of stimulants in pediatric practice settings: A national perspective. Journal of Developmental and Behavioral Pediatrics: JDBP, 21(5), 322–331.PubMed

Jones, S., & Fox, S. (2009) Generations online in 2009. Pew Internet and American life project. http://www.pewinternet.org/Reports/2009/Generations-Online-in-2009. Accessed May 20, 2009.

Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the autism society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12(4), 311–321.CrossRefPubMed

Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441–e448.CrossRefPubMed

Mandell, D. S., & Palmer, R. (2005). Differences among states in the identification of autistic spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 159(3), 266–269.CrossRefPubMed

Martin, A., Scahill, L., Klin, A., & Volkmar, F. R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 923–931.CrossRefPubMed

Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002). Datapoints: Use of multiple psychotropic drugs by medicaid-insured and privately insured children. Psychiatric Services (Washington, D.C.), 53(12), 1508.

Myers, S. M., Johnson, C. P., & American Academy of Pediatrics Council on Children With Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.CrossRefPubMed

National Center for Health Statistics. (2006) NCHS urban–rural classification scheme for counties. Retrieved November 15, 2008, from http://www.cdc.gov/nchs/r&d/rdc_urbanrural.htm.

Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63(6), 679–685.CrossRefPubMed

Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17(3), 348–355.CrossRefPubMed

Posey, D. J., Stigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. The Journal of Clinical Investigation, 118(1), 6–14.CrossRefPubMed

Safer, D. J., Zito, J. M., & Gardner, J. F. (2004). Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services (Washington, D.C.), 55(9), 1049–1051.

Shimabukuro, T. T., Grosse, S. D., & Rice, C. (2008). Medical expenditures for children with an autism spectrum disorder in a privately insured population. Journal of Autism and Developmental Disorders, 38(3), 546–552.CrossRefPubMed

Tsai, L. Y. (1999). Psychopharmacology in autism. Psychosomatic Medicine, 61(5), 651–665.PubMed

US Census Bureau. (2008). Retrieved October 31, 2008, from http://factfinder.census.gov.

Volkmar, F. R. (2001). Pharmacological interventions in autism: Theoretical and practical issues. Journal of Clinical Child Psychology, 30(1), 80–87.CrossRefPubMed

Williams, J., Klinepeter, K., Palmes, G., Pulley, A., & Foy, J. M. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics, 114(3), 601–606.CrossRefPubMed

Witwer, A., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 671–681.CrossRefPubMed

Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services (Washington, D.C.), 56(2), 157–163.

Titel: Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008
Auteurs: Rebecca E. Rosenberg
David S. Mandell
Janet E. Farmer
J. Kiely Law
Alison R. Marvin
Paul A. Law
Publicatiedatum: 01-03-2010
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 3/2010
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-009-0878-1

Andere artikelen Uitgave 3/2010

Sarah Attwood: Making Sense of Sex: A Forthright Guide to Puberty, Sex, and Relationships for People with Asperger’s Syndrome

Book Review

M. Suzanne Zeedyk (ed.): Promoting Social Interaction for Individuals with Communicative Impairments: Making Contact

Book Review

Emotion Recognition in Children with Autism Spectrum Disorders: Relations to Eye Gaze and Autonomic State

Original Paper

Efficacy of Brief Quantitative Measures of Play for Screening for Autism Spectrum Disorders

Original Paper

The Medical Home for Children with Autism Spectrum Disorders: Parent and Pediatrician Perspectives

Original Paper

Further Empirical Data on the Psychoeducational Profile-Revised (PEP-R): Reliability and Validation with the Vineland Adaptive Behavior Scales

Original Paper